EDA Logo
Sorry, this website does not support this browser

Public Assessment Reports (PAR)

CA Of biologicals product and Innovation and Clinical study

CA Of biologicals product and Innovation and Clinical study

Publishing a product profile that includes information about the product itself, the manufacturer, the therapeutic indications, and a brief overview of the manufacturing process without compromising the privacy principles or intellectual property rights of each company. It also includes the clinical studies and trials conducted on the product that have been approved by the Egyptian Drug Authority.Target Audience: Medical professionals (such as hospital physicians, etc.), researchers, companies, and the general public.Publication Language: To be issued in English.

Public Assessment Report 2023-2024

Public Assessment Report 2025

Public Assessment Report 2026

EDA-CT Application(s) Assessment Summary Publication Report (CT-ASPR) 2023-2024

EDA-CT Application(s) Assessment Summary Publication Report (CT-ASPR) 2026

Copy Rights @ EDA 2021